PeerView Clinical Pharmacology CME/CNE/CPE Video
Podcast image
Mrinal Gounder, MD - Paving the Path Forward for Desmoid Tumors: Multidisciplinary Tactics to Effectively Implement Gamma Secretase Inhibitors in Clinical Practice
60 hours 26 mins; April 01, 2026
Peter A. Campochiaro, MD / Diana V. Do, MD - Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing
57 mins; March 24, 2026
Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition
51 mins; March 24, 2026
Ellen R. Sher, MD - A Life Less Stuffy for Patients With Perennial Allergic Rhinitis: Exploring Targeted Treatment Approaches to Improve Quality of Life
56 mins; March 24, 2026
Michael R. Gieske, MD, Nichole T. Tanner, MD, MSCR - Real-World Strategies and Workflows for Lung Cancer Screening Success in Diverse Populations: Enhancing Vigilance to Increase Early Detection on the Front Lines of Care
53 mins; March 24, 2026
Dana M. Chase, MD, FACOG - Charting New Territories in Endometrial Cancer Care: Insights for Personalizing Treatment With Biomarker-Informed Therapies
64 hours 29 mins; March 19, 2026
Brooke E. Howitt, MD / Kathleen N. Moore, MD, MS, FASCO - Pathway to Precision in Ovarian Cancer: A Pathology-Informed Guide to Translating Biomarker Testing Results Into Actionable Treatment With ADCs
51 mins; March 19, 2026
Amit Bar-Or, MD, FRCPC, FAAN, FANA / Tanuja Chitnis, MD, MA, FAAN, FANA - Neuroinflammation in Focus: Interpreting the Latest Evidence for BTK Inhibition in Multiple Sclerosis
55 mins; March 19, 2026
Heather A. Wakelee, MD, FASCO, Helena A. Yu, MD - Data and Decisions in Advanced NSCLC: Addressing Open Questions to Optimize Immunotherapy and Targeted Options
54 mins; March 19, 2026
Robert (Bob) J. Fox, MD, Jiwon Oh, MD, PhD, FRCPC - Disease and Disability Progression in Relapsing MS: Unpacking Efficacy Data to Advance Treatment Decisions
52 mins; March 12, 2026
Cecelia Damask, DO - Building on the Path in CRSwNP: Targeting Upstream Drivers With the Latest Biologic Approaches
29 mins; March 12, 2026
Barbara Burtness, MD - New Immunotherapy Frontiers in R/M HNSCC: Multidisciplinary Perspectives on Advancing Care in Challenging Patient Populations
51 mins; March 12, 2026
Juan Fortea, MD, PhD / Professor Frank Jessen, MD - Strategies for Appropriate Assessment and Use of APOE Status in Alzheimer’s Disease: Clinical Care in Europe
46 mins; March 12, 2026
Aarti Bhatia, MD, MPH / Deborah J. Wong, MD, PhD - Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings
53 mins; March 04, 2026
Toby Maher, MD, MSc, PhD - Rethinking Pulmonary Fibrosis: From Fine-Tuning Diagnosis to Illuminating Novel Pathways for Emerging Treatment Strategies
54 mins; March 04, 2026
Seema S. Aceves, MD, PhD - Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care
29 mins; March 04, 2026
Samuel Cytryn, MD / Daniela Molena, MD / Manish A. Shah, MD, FASCO - Synchronizing Success in Resectable Gastric/GEJ Cancer: Merging Expertise to Effectively Deliver Immunotherapy Platforms in the Surgical Setting
60 hours 3 mins; March 04, 2026
Anju T. Peters, MD, MS, Michael Platt, MD, MSc - Treating With Precision in CRSwNP: Defining the Role of Targeted Biologic Therapy for Optimal Patient Outcomes
56 mins; February 24, 2026
Suzanne E. Schindler, MD, PhD - Preparing for the New Era of Blood-Based Biomarkers in Alzheimer’s Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows
96 hours 38 mins; February 24, 2026
Thomas Grader-Beck, MD - Sjögren’s Disease and the B-Cell Frontier: What Clinicians Need to Know Now to Prepare for Future Therapies
69 hours 22 mins; February 24, 2026
Ana C. Garrido-Castro, MD - TROP2-Targeting ADCs in the Forefront: Changing Standards and Best Practices in TNBC and HR+, HER2- Breast Cancer Care
37 mins; February 24, 2026
Roxana Mehran, MD / Jeffrey Weitz, MD, FRCPC, FRSC, FACP - Navigating the Path to Next-Generation Anticoagulation Strategies: Rising to the Challenge of Unmet Needs in SSP and AF
35 mins; February 24, 2026
Lauren A. Byers, MD - The ADC Wave in SCLC: Emerging Evidence and Practical Considerations for New Options on the Horizon
27 mins; February 17, 2026
Prof. Kevin J. Harrington, FCRP, FRCR, FRSB, PhD / Prof. Christophe Le Tourneau, MD, PhD - Staying Current on Immunotherapy for HNSCC: Conversations on Clinical Collaboration and Treatment Selection
37 mins; February 17, 2026
Simron Singh, MD, MPH - Catalysts for Enhanced Patient CARE In Neuroendocrine Neoplasms: Clinical Adoption of Rapidly Emerging Evidence on Novel Therapeutic Strategies
78 hours 29 mins; February 17, 2026
Phillip H. Kuo, MD, PhD / Jonathan E. McConathy, MD, PhD, FSNMMI - Alzheimer’s Disease Case Conference: Building Confidence in Visual Interpretation and Quantitative Analysis of Neuroimaging
64 hours 7 mins; February 17, 2026
Prof. Dr. Peter R. Galle - Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum
92 hours 44 mins; February 12, 2026
Brooke Looney, PharmD, CSP / Alicia K. Morgans, MD, MPH, FASCO - Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans
49 mins; February 12, 2026
MeiLan K. Han, MD, MS / Fernando J. Martinez, MD, MS - ECHOing Innovation in COPD: Transforming Patient Care With the Use of Targeted Biologic Therapy
56 mins; February 04, 2026
Jaume Capdevila, MD, PhD - From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas
32 mins; February 04, 2026
Nicole Lamanna, MD, Lydia Scarfò, MD - Choices, Changes, and Global Perspectives in CLL Care: Real-World Insights and New Evidence on Finite Therapy With Targeted Agents
36 mins; February 04, 2026
Elizabeth R. Volkmann, MD, MS - Frameworks for Identifying Systemic Sclerosis and Its Complications: From Pathophysiology to Personalized Care
55 mins; January 22, 2026
Nicola Gökbuget, MD - Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies
78 hours 35 mins; January 14, 2026
Stephen V. Liu, MD - Innovation Takes the Lead in SCLC: Leveraging Evolving Advances to Drive Improved Outcomes in Limited- and Extensive-Stage Disease
55 mins; January 14, 2026
Benjamin C. Creelan, MD - Taking the High Road in NSCLC: Navigating Through Immunotherapy-Based Treatments to Optimize Outcomes
25 mins; January 14, 2026
Asuncion Mejias, MD, PhD - RSV Prophylaxis Unveiled: What Healthcare Providers Need to Know
28 mins; January 14, 2026
David A. Sallman, MD - Menin Masters for AML Care: Guidance on Integrating Menin Inhibitor Regimens and Boosting Efficacy in Challenging AML Subtypes
77 hours 40 mins; January 13, 2026
Guillermo Garcia-Manero, MD - MASTER MDS for Enhanced Patient Care: Modern Advances With Standard and Emerging Risk-Adapted Treatment
70 hours 18 mins; January 13, 2026
Sagar Lonial, MD, FACP - Many Roads to Myeloma Remission: Making Sequential Choices With BCMA and Non-BCMA Immunotherapies
82 hours 0 mins; January 13, 2026
Professor John G. Gribben, MD, DSc - Pathways to Personalized Remission in CLL: Leveraging Targeted Standards and Next-Gen Advances for Upfront and Sequential Care
112 hours 46 mins; January 13, 2026
Prof. Dr. Max S. Topp, MD - Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond
84 hours 28 mins; January 13, 2026
Prof. Dr. Martin Dreyling - Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options and Modern Clinical Decision-making in Newly Diagnosed Disease
79 hours 21 mins; January 13, 2026
Zachariah DeFilipp, MD - Rising to the Graft-vs-Host Disease Challenge: Progress in Treatment and Post-HCT Outcomes Across Hematologic Cancers
81 hours 35 mins; January 13, 2026
Komal Jhaveri, MD, FACP - Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations: A Framework for Multifactorial Clinical Decisions
81 hours 46 mins; January 13, 2026
Joyce O'Shaughnessy, MD - Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcome
88 hours 20 mins; January 13, 2026
Noel Clarke, MBBS, FRCS ChM / Joaquin Mateo, MD, PhD / Isabela Werneck da Cunha, MD, PhD, MBA - New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies
37 mins; January 13, 2026
Prof. Solange Peters, MD, PhD / Prof. David Planchard, MD, PhD - The Challenges of Choice in First-Line EGFRm NSCLC: Practical Guidance on Optimising Treatment Approaches
40 mins; January 13, 2026
Jennifer Woyach, MD - Revealing New Sequences in CLL: Collaborative Care Planning With Real-World Evidence and Modern Therapeutics
52 mins; January 13, 2026
Prof. Eric Van Cutsem, MD, PhD - Precision Tactics With HER2-Targeting ADCs in HER2-Altered Solid Tumors: Candid Conversations and Clinical Consults
78 hours 55 mins; January 13, 2026
Sia Daneshmand, MD - Elevating NMIBC Care: Putting the Latest Innovations for Intravesical Therapies Into Practice
26 mins; January 13, 2026
Alireza Atri, MD, PhD, Malaz Boustani, MD, MPH - Implementing Innovation in Alzheimer’s Care: Practical Approaches to Adopting New Diagnostics and Disease-Modifying Treatments
70 hours 51 mins; January 09, 2026
Prof. Elisabeth Botelho-Nevers, MD, PhD / Prof. Federico MartinĂłn-Torres, MD, PhD - Shielding Generations With Pneumococcal Vaccination Approaches Across the Lifespan
41 mins; January 09, 2026
Barbara Burtness, MD / Ravindra Uppaluri, MD, PhD, FACS - Definitive Innovation in Resectable Head and Neck Cancer: New Immunotherapy Approaches in LA-HNSCC
59 mins; January 09, 2026
Fred Saad, CQ, MD, FRCS, FCAHS - Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment
61 hours 51 mins; January 09, 2026
Gary S. Marshall, MD - Prevention at Every Age: A Team-Based Approach to Meningococcal Disease Vaccination for At-Risk Populations
46 mins; January 09, 2026
Erik Musiek, MD, PhD - Strategies for Appropriate Assessment and Use of APOE Status in Alzheimer’s Disease: Clinical Care in the United States
53 mins; January 09, 2026
Ibiayi Dagogo-Jack, MD, FASCO, Van Karlyle Morris, MD - Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings
51 mins; January 09, 2026
William D. Tap, MD - Achieving Disease Control in TGCT: Critical Steps For Integrating Evidence-Based Care With CSF1R Inhibitors
69 hours 38 mins; December 31, 2025
Geoffrey Ku, MD - Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians
46 mins; December 29, 2025
Gil Rabinovici, MD - Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Management of Alzheimer's Disease: Breaking Updates From CTAD 2025
31 mins; December 29, 2025
Manmeet S. Ahluwalia, MD, MBA, FASCO - Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Evidence on Molecularly Targeted Therapies in IDH-Mutant Disease
64 hours 19 mins; December 29, 2025
Thomas Grader-Beck, MD - Beneath the Surface of Sjögren’s Disease: Understanding Systemic Impact and B-Cell–Mediated Pathways
40 mins; December 29, 2025
Scott A. Kaiser, MD / Lisa C. McGuire, PhD, FGSA - Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia
72 hours 13 mins; December 26, 2025
Milind Desai, MD, MBA, Anjali Tiku Owens, MD - Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors
56 mins; December 26, 2025
Prof. Dr. Konstanze Döhner - The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease
39 mins; December 18, 2025
Joseph K. Han, MD, FARS, FAAAAI - Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!
60 hours 44 mins; December 18, 2025
Christine Franzese, MD, FARS, Flavia C.L. Hoyte, MD, FACAAI - The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments
61 hours 42 mins; December 12, 2025
Ahmad Masri, MD, MS, Nitasha Sarswat, MD - Contemporary Insights on Diagnosing and Treating Transthyretin Cardiac Amyloidosis: How I Think, How I Treat
82 hours 46 mins; December 12, 2025
Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease
68 hours 20 mins; December 12, 2025
Jay H. Shubrook, DO, FAAFP, FACOFP - Guiding Patients Through Cardio-Renal-Metabolic Conditions: The Essential Role of Primary Care Clinicians
62 hours 46 mins; December 05, 2025
Tatyana Kushner, MD, MSCE, Paul Kwo, MD, AGAF, FACG, FAASLD - Toward Functional Cure in Chronic HBV: Monitoring, Serological Markers, and Evolving Therapy
58 mins; December 05, 2025
Antonio Anzueto, MD / Professor Dave Singh - Addressing an Exacerbating Issue in COPD: Strategies for Individualized Targeted Biologic Therapy to Improve Quality of Life
55 mins; December 05, 2025
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care
35 mins; December 03, 2025
David N. Lieberman, MD, PhD - Building Clinical Confidence in the Diagnosis and Multidisciplinary Management of Rett Syndrome
23 mins; December 03, 2025
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration
38 mins; December 03, 2025
Bruce E. Sands, MD, MS - Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis
60 hours 50 mins; December 03, 2025
Philip J. Mease, MD, MACR - Taking a New Look at Psoriatic Arthritis and Its Comorbidities Through the Lens of TYK2 Inhibition
74 hours 12 mins; December 03, 2025
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases
70 hours 57 mins; December 03, 2025
Professor Julian Gillmore / Mathew S. Maurer, MD - Exploring New Paradigms in Transthyretin Cardiac Amyloidosis Care: Experts vs AI
54 mins; November 20, 2025
Toby Maher, MD, MSc, PhD - Clearing the Air on Fibrosing ILDs: Pulmonologist Conversations on Timely Diagnosis and Modern Care With Antifibrotic Therapy
56 mins; November 20, 2025
John B. Buse, MD, PhD / Pam R. Taub, MD, FACC, FASPC - To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies
63 hours 31 mins; November 20, 2025
Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy Platforms
49 mins; November 20, 2025
Malaz Boustani, MD, MPH, Charles Vega, MD, FAAFP - Brain Health Morning Report: Adapting Primary Care Practice and Workflows to Meet the Needs of an Aging Population
61 hours 46 mins; November 13, 2025
Jiwon Oh, MD, PhD, FRCPC - Quiet Progression, Loud Impact in MS: Expert Insights on the Role of BTK Inhibitors Beyond Relapse
34 mins; November 13, 2025
Prof. Dr. med. Alexander Drzezga - Nuclear Medicine for Alzheimer’s Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers
69 hours 59 mins; November 13, 2025
Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents
71 hours 36 mins; October 31, 2025
Michelle Kittleson, MD, PhD - Implementing Targeted Therapies in Transthyretin Cardiac Amyloidosis: From Diagnosis to Stabilization
53 mins; October 31, 2025
April W. Armstrong, MD, MPH - Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care
47 mins; October 31, 2025
Arun J. Sanyal, MBBS, MD - Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health
44 mins; October 30, 2025
Stuart C. Gordon, MD, FACP, FACG, AGAF, FAASLD - Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management
36 mins; October 30, 2025
Paolo Ghia, MD, PhD - The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations
53 mins; October 27, 2025
Aleena Banerji, MD - Improving the Care of Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis
52 mins; October 27, 2025
Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health
56 mins; October 27, 2025
Milind Desai, MD, MBA / Anjali Tiku Owens, MD - Fine-Tuning Hypertrophic Cardiomyopathy Care in the CMI Era: Redefining Management for the Modern Heart Failure Specialist
58 mins; October 27, 2025
Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC
42 mins; October 27, 2025
Jared R. Brosch, MD - Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer’s Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management
55 mins; October 17, 2025
Peter A. Campochiaro, MD - Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care
58 mins; October 17, 2025
Sandeep K. Gupta, MD, AGAF, FACG, FASGE, Jenifer R. Lightdale, MD, MPH - Fast Track to Relief: Accelerating Treatment Initiation and Supporting Patient Follow-Up in Pediatric Eosinophilic Esophagitis
50 mins; October 17, 2025
Michelle C. Kaku, MD / Chafic Karam, MD - Targeted Therapy for Hereditary Transthyretin Amyloidosis Polyneuropathy (ATTRv-PN): You Don’t Want to Miss It!
58 mins; October 17, 2025
Kent E. Vrana, PhD, FAAAS, FASPET - Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making
34 mins; October 03, 2025